Rituximab in combination with high-dose dexamethasone for the treatment of relapsed/refractory chronic lymphocytic leukemia
Leukemia Research, 08/16/2012
Clinical Article
Smolej L et al. – Dexamethasone combined with rituximab (R–dex) appears to be an active and feasible treatment for relapsed/refractory chronic lymphocytic leukemia (CLL). Infectious toxicity remains an important issue.



